Application of Prebiotics and Postbiotics in Vaginal Infections
DOI:
https://doi.org/10.54097/mh9e8n15Keywords:
Prebiotics, Postbiotics, Vaginal Infections, Bacterial Vaginosis, Vulvovaginal CandidiasisAbstract
Vaginal health is crucial for women's overall well-being. Decades of research have established that colonization and dominance by Lactobacillus species are fundamental characteristics of a healthy vaginal microbiota. Susceptibility factors, including menstruation, pregnancy, sexual activity, antibiotic overuse, and vaginal douching, can disrupt this microbial community. Such disturbances may lead to pathogenic overgrowth, resulting in common infections like bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC). The dominance of vaginal Lactobacillus is essential for preventing these conditions. Recently, the use of prebiotic and postbiotic preparations to support the growth of vaginal lactobacilli has gained considerable interest. Although research on their vaginal application is still in its early stages, growing evidence suggests that prebiotics and postbiotics can help regulate the vaginal microbiota by promoting beneficial probiotics and inhibiting pathogens, thereby maintaining vaginal health. This review compiles published evidence on the use of prebiotics and postbiotics in managing vaginal infections, aiming to overcome the limitations of existing treatments and provide insights for clinical practice.
Downloads
References
[1] Gibson GR, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. PMID: 28611480
[2] Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. doi:10.1038/s41575-021-00440-6. PMID: 33948025.
[3] Davani-Davari D, Negahdaripour M, Karimzadeh I, et al. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods. 2019;8(3):92. doi:10.3390/ foods 8030092. PMID: 30857324.B. Smith, “An approach to graphs of linear forms (Unpublished work style),” unpublished.
[4] Lopez-Santamarina A, Miranda JM, Lamas A, et al. Potential Use of Marine Seaweeds as Prebiotics: A Review. Molecules. 2020;25(6):1004. doi:10.3390/molecules25061004. PMID: 32244939.
[5] Tian H, et al. Prebiotic effects of bovine lactoferrin on specific probiotic bacteria. Biometals. 2017;30(3):377-386. PMID: 28185076
[6] Zielińska D, Kolozyn-Krajewska D. Antimicrobial and Prebiotic Activity of Lactoferrin in the Female Reproductive Tract: A Comprehensive Review. Biomedicines. 2021;9(12): 1940. doi:10.3390/biomedicines9121940. PMID: 34944741.
[7] Ashaolu TJ. Plant Prebiotics and Their Role in the Amelioration of Diseases. Biosci Biotechnol Biochem. 2021;85 (4): 809-819. doi:10.1093/bbb/zbaa192. PMID: 33724231.
[8] Cunningham M, Azcarate-Peril MA, Barnard A, et al. Shaping the Future of Probiotics and Prebiotics. Trends Microbiol. 2021;29(8):667-685. doi: 10.1016/j.tim.2021.01.005. PMID: 33551269.
[9] Sabater C, et al. Novel and emerging prebiotics: Advances and opportunities. Adv Food Nutr Res. 2021; 95: 21-58. PMID: 33745516.
[10] Salminen S, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. PMID: 33948025 IF: 51.0 Q1 .
[11] Cuevas-González PF, Frías-De-Diego A, Liceaga AM, et al. Promising bioactivities of postbiotics: A comprehensive review. J Agric Food Chem. 2023;71(42):15506-15521. doi:10. 1021/ acs. jafc.2c08734. PMID: 37850863.
[12] Wang J, Ji H, Zhang W, et al. The Role of Inactivation Methods in Shaping Postbiotic Composition and Biological Activity. Foods. 2024;13(13):2358. doi:10.3390/foods13132358. PMID: 38998519.
[13] Thorakkattu P, Khanashyam AC, Shah K, et al. Postbiotics: Current Trends in Food and Pharmaceutical Industry. Foods. 2022;11(18):3094. doi:10.3390/foods11183094. PMID: 36141 022.
[14] Nataraj BH, Shivanna SK, Rao P, et al. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb Cell Fact. 2020;19(1):168. doi:10.1186/s12934-020-01426-w. PMID: 32819347.
[15] Piazzi M, Bubeck AM, Teschner D, et al. Effect of Thermal Inactivation on Antioxidant, Anti-Inflammatory Activities and Chemical Profile of Postbiotics. Antioxidants (Basel).
[16] Rousseau V, Lepargneur JP, Roques C, et al. Prebiotic effects of oligosaccharides on selected vagina microflora in vitro. FEMS Microbiol Lett. 2005;247(1):133-8. doi:10.1016/j. femsle.2005.04.030. PMID: 15869932.
[17] Costabile A, Bergillos-Meca T, Landriscina L, et al. Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota. Appl Environ Microbiol. 2018;84(5): e02200-17. doi:10.1128/AEM.02200-17. PMID: 29222097.
[18] Faustino M, et al. Vaginal prevention of Candida albicans: synergistic effect of lactobacilli and mannan oligosaccharides (MOS). Appl Microbiol Biotechnol. 2024;108(1):73. PMID: 38194142 .
[19] Yeh SL, et al. Inhibitory effects of a soluble dietary fiber from Amorphophallus konjac on cytotoxicity and DNA damage induced by fecal water in Caco-2 cells. Planta Med. 2007;73(13):1384-8. PMID: 17893827.
[20] Sanjeevani Shekhar S, Godbole G, Dhaval B, et al. In vitro and in vivo evaluation of prebiotic potential of pectin on vaginal lactobacilli. Curr Microbiol. 2022;79(2):48. doi:10.1007/ s00284-021-02745-4. PMID: 34997318.
[21] Liu J, Li Y, Sun Y, et al. [Therapeutic effect of isomalto-oligosaccharide gel on vulvovaginal candidiasis in rats]. Zhonghua Fu Chan Ke Za Zhi. 2015;50(9):686-90. Chinese. PMID: 26678209.
[22] Beigi B, Al-Ghazzewi FH, Khanna S, et al. Effects of hydrolysed konjac glucomannan on a murine model of bacterial vaginosis. J Appl Microbiol. 2009;107(5):1630-5. doi: 10. 1111/j.1365-2672.2009.04345. x. PMID: 19486411.
[23] Lanza M, Casili G, Filippone A, et al. Effects on Vaginal Microbiota Restoration and Cervical Epithelialization in Positive HPV Patients Undergoing Vaginal Treatment with Carboxy-Methyl-Beta-Glucan. Biomed Res Int. 2020; 2020: 5476389. doi:10.1155/2020/5476389. PMID: 32420349.
[24] Gong Z, Luna Y, Yu P, Fan H. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS One. 2014;9(9):e107758. doi:10.1371/journal.pone.0107758. PMID: 25259626.
[25] Sanjeevani Shekhar S, Godbole G, Dhaval B, et al. In vitro and in vivo evaluation of prebiotic potential of pectin on vaginal lactobacilli. Curr Microbiol. 2022;79(2):48. doi:10.1007/ s00284-021-02745-4. PMID: 34997318.
[26] Costabile A, Bergillos-Meca T, et al. Safety and Efficacy of an Intravaginal Prebiotic Gel in the Prevention of Recurrent Bacterial Vaginosis: A Randomized Double-Blind Study. Obstet Gynecol Int. 2012; 2012:147867. doi:10.1155/ 2012/ 147867. PMID: 23226906.
[27] Dec M, Puchalski A, Wernicki A, et al. The effect of isomalto-oligosaccharide vaginal gel on vulvovaginal candidiasis: A randomized clinical trial. Ginekol Pol. 2020;91(6):312-317. doi:10.5603/GP.2020.0058. PMID: 32627152.
[28] Al-Ghazzewi FH, Tester RF. Beneficial health characteristics of native and hydrolysed konjac (Amorphophallus konjac) glucomannan. J Sci Food Agric. 2016;96(9):3283-91. doi: 10. 1002/ jsfa.7571. PMID: 26676986.
[29] Otsuki K, Imai N. Effects of lactoferrin in 6 patients with refractory bacterial vaginosis. Biochem Cell Biol. 2017;95 (1):31-33. doi:10.1139/bcb-2016-0051. PMID: 28099070.
[30] Pino A, Giunta G, Randazzo CL, et al. Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis. 2017; 28(1):1357417. doi:10.1080/16512235.2017.1357417. PMID: 28959186.
[31] Xiao B, Zhang D, Chen R, et al. Sucrose gel for treatment of bacterial vaginosis: a randomized, double-blind, multi-center, parallel-group, phase III clinical trial. Beijing Da Xue Xue Bao Yi Xue Ban. 2015;47(6):925-32. PMID: 26679650.
[32] Trupakova I, Kazakova T, et al. Experience of inulin use for correcting intestinal microbiota in patients suffering from recurrent vulvovaginal candidiasis: A prospective cohort comparative study. Akush Ginekol (Sofiia). 2023;62(4):3-9.
[33] Delgado-Diaz DJ, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6:164. PMID: 26082720 .
[34] Tachedjian G, et al. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9-10):782-792. PMID: 28435139.
[35] Holm JB, et al. Commensal Lactobacilli Metabolically Contribute to Cervical Epithelial Homeostasis in a Species-Specific Manner. mSphere. 2023;8(1):e0045222. PMID: 366 29413 .
[36] Delgado-Diaz DJ, Tyssen D, Hayward JA, et al. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression. Microbiome. 2022;10(1):141. doi:10.1186/s40168-022-01337-5. PMID: 36042467.
[37] Puri K, et al. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol India. 2006;56(2):152-155. PMID: 16594932 .
[38] Nami Y, et al. The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria. Probiotics Antimicrob Proteins. 2022;14(5):986-1004. PMID: 34907656 .
[39] Matsubara VH, et al. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl Microbiol Biotechnol. 2016;100(14):6415-6426. PMID: 27087525 .
[40] Jang SJ, et al. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans. Sci Rep. 2019;9(1):8121. PMID: 31148560 .
[41] Powell AM, et al. Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interconnections and Therapeutic Implications. Infect Dis Clin North Am. 2023;37 (4): 739-758. PMID: 38257934 .
[42] Sobel JD, Nyirjesy P. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. Curr Infect Dis Rep. 2011; 13 (4): 359-66. PMID: 21774671.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

